Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Hybridoma ; 11(4): 447-59, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1383125

ABSTRACT

Monoclonal antibodies (MAbs) were generated against human CD16 (Fc gamma RIII) by fusion of NS1 myeloma cells with spleen cells from BALB/c mice immunized with synthetic peptide sequences derived from the CD16 genes. After screening, four hybridomas secreting MAbs (2 IgM and 2 IgG) were selected, cloned and characterized for their activity against CD16 by ELISA test, flow cytometry, rosette inhibition and immuno-blotting. MAbs reacted strongly in ELISA with a soluble form of CD16 (sCD16) present in human serum and to a lesser degree with soluble recombinant CD16 (srCD16). The binding characteristics of the four antibodies to the sCD16 were different, implying that the antibodies recognize different CD16 epitopes. FACS analysis of peripheral blood from healthy volunteers demonstrated that these MAbs are highly reactive with membrane CD16 of neutrophils cells (70-95%) and with a subset of lymphocytes (6-14%). These MAbs seem interesting and may lead to the purification of the soluble human CD16 and to the knowledge of its functions, its physiological role and the cellular polymorphism.


Subject(s)
Antibodies, Monoclonal/biosynthesis , Peptide Fragments/immunology , Receptors, IgG/immunology , Amino Acid Sequence , Animals , Antibodies, Monoclonal/isolation & purification , Antibody Specificity , Epitopes/chemistry , Humans , Hybridomas/immunology , Mice , Molecular Sequence Data , Peptide Fragments/chemistry , Receptors, IgG/chemistry , Solubility
2.
Biochimie ; 73(11): 1391-6, 1991 Nov.
Article in English | MEDLINE | ID: mdl-1799632

ABSTRACT

The crystal structure of the aspartyl protease encoded by the gene pol of the human immunodeficiency virus (HIV-1, isolate BRU) has been determined to 2.7 A resolution. The enzyme, expressed as an insoluble denatured polypeptide in inclusion bodies of Escherichia coli has been renatured and crystallized. It differs by several amino acid replacements from the homologous enzymes of other HIV-1 isolates. A superposition of the C alpha-backbone of the BRU protease with that of the SF2 protease gives a roots mean square positional difference of 0.45 A. Thus, neither the denaturation/renaturation process nor the amino acid replacements have a noticeable effect on the three-dimensional structure of the BRU protease or on the detailed conformation of the catalytic site, which is very similar to that of other aspartyl proteases.


Subject(s)
HIV Protease/chemistry , Cloning, Molecular , Computer Simulation , Escherichia coli , HIV-1/enzymology , Models, Molecular , Protein Conformation , X-Ray Diffraction
3.
J Biol Chem ; 265(14): 7733-6, 1990 May 15.
Article in English | MEDLINE | ID: mdl-2186027

ABSTRACT

By replacement of the P1' residue in a capsid/nucleocapsid cleavage site mimic with 4-NO2-phenylalanine (Nph), an excellent chromogenic substrate, Lys-Ala-Arg-Val-Leu*Nph-Glu-Ala-Met, for HIV-1 proteinase (kappa cat = 20 s-1, Km = 22 microM) has been prepared. Substitution of the Leu residue in P1 with norleucine, Met, Phe, or Tyr had minimal effects on the kinetic parameters (kappa cat and kappa cat/Km) determined at different pH values, whereas peptides containing Ile or Val in P1 were hydrolyzed extremely slowly. The spectrophotometric assay has been used to characterize the proteinase further with respect to pH dependence, ionic strength dependence, and the effect of competitive inhibitors of various types.


Subject(s)
Chromogenic Compounds/metabolism , Endopeptidases/metabolism , Gene Products, pol/metabolism , HIV-1/enzymology , Oligopeptides/metabolism , Amino Acid Sequence , Binding, Competitive , Chromogenic Compounds/chemical synthesis , Gene Products, gag/metabolism , HIV Protease , Hydrogen-Ion Concentration , Hydrolysis , Kinetics , Molecular Sequence Data , Oligopeptides/chemical synthesis , Osmolar Concentration , Peptide Fragments/metabolism , Phenylalanine/analogs & derivatives , Protease Inhibitors , Spectrophotometry , Structure-Activity Relationship , Substrate Specificity
4.
Proc Natl Acad Sci U S A ; 86(21): 8247-51, 1989 Nov.
Article in English | MEDLINE | ID: mdl-2682640

ABSTRACT

In a significant fraction of the Escherichia coli cytosolic proteins, the N-terminal methionine residue incorporated during the translation initiation step is excised. The N-terminal methionine excision is catalyzed by methionyl-aminopeptidase (MAP). Previous studies have suggested that the action of this enzyme could depend mainly on the nature of the second amino acid residue in the polypeptide chain. In this study, to achieve a systematic analysis of the specificity of MAP action, each of the 20 amino acids was introduced at the penultimate position of methionyl-tRNA synthetase of E. coli and the extent of in vivo methionine excision was measured. To facilitate variant protein purification and N-terminal sequence determination, an expression shuttle vector based on protein fusion with beta-galactosidase was used. From our results, methionine excision catalyzed by MAP is shown to obey the following rule: the catalytic efficiency of MAP, and therefore the extent of cleavage, decreases in parallel with the increasing of the maximal side-chain length of the amino acid in the penultimate position. This molecular model accounts for the rate of N-terminal methionine excision in E. coli, as deduced from the analysis of 100 protein N-terminal sequences.


Subject(s)
Bacterial Proteins/genetics , Cysteine/metabolism , Escherichia coli/genetics , Protein Processing, Post-Translational , Amino Acid Sequence , Bacterial Proteins/isolation & purification , Chimera , Codon/genetics , Escherichia coli/metabolism , Genes, Bacterial , Genetic Vectors , Molecular Sequence Data , Mutation
5.
Biochimie ; 70(6): 773-82, 1988 Jun.
Article in English | MEDLINE | ID: mdl-3139093

ABSTRACT

The construction of a family of plasmids carrying derivatives of metG, the gene for E. coli methionyl-tRNA synthetase, is described. These plasmids allow expression of native or truncated forms of the enzyme and easy purification of the products. To facilitate the characterization of modified enzymes with very low catalytic activity, a specialized vector was constructed, in which metG was fused in frame with lacZ, the gene for beta-galactosidase. This plasmid expresses a methionyl-tRNA synthetase-beta-galactosidase chimeric protein, which is shown to carry the activities of both enzymes. This hybrid can be purified in a single step of affinity chromatography for beta-galactosidase. The methionyl-tRNA synthetase moiety can be regenerated by mild proteolysis, thus providing a simple method for purifying and studying mutated proteins.


Subject(s)
Amino Acyl-tRNA Synthetases/genetics , Chimera , Galactosidases/metabolism , Methionine-tRNA Ligase/genetics , Protein Engineering/methods , beta-Galactosidase/metabolism , Escherichia coli/genetics , Genetic Vectors , Mutation , Peptide Hydrolases/metabolism , Plasmids
SELECTION OF CITATIONS
SEARCH DETAIL
...